Epidemiology of necrotizing meningoencephalitis in pug dogs

Journal of Veterinary Internal Medicine

Volumn 22, Issue 4, 2008, Pages 961-968

  Levine, Jonathan M ^a   Fosgate, G T ^a   Porter, B ^a   Schatzberg, S J ^b   Greer, K ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c NONE

Author keywords

Central nervous system; Encephalitis; Inflammation

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MENINGOENCEPHALITIS;

ANIMALS; DOG DISEASES; DOGS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MALE; MENINGOENCEPHALITIS;

ANIMALIA; CANIS FAMILIARIS;

EID: 47849102394     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0137.x     Document Type: Article

References (51)

1. Cordy DR, Holliday TA. A Necrotizing meningoencephalitis of Pugdogs. Vet Pathol 1989;26:191-194.
2. Higginbotham MJ, Kent M, Glass EN. Noninfectious inflammatory central nervous system diseases in dogs. Cornpend Contin Educ Pract Vet 2007;29:488-497.
3. Summers BA, Cummings JF, De Lahunta A. Inflammatory diseases of the central nervous system. In: Veterinary Neuropathology. St Louis, MO: Mosby; 1995;95-188.
4. Kobayashi Y, Ochiai K, Umemura T., et al. Necrotizing meningoencephalitis in Pug dogs in Japan. J Comp Pathol 1994;110:129-136.
5. Hasegawa T, Uchida K, Sugimoto M, et al. Long-term management of necrotizing meningoencephalitis in a Pug dog. Can Pract 2000;25:20-22.
6. Kuwabara M, Tanaka S, Fujiwara K. Magnetic resonance imaging and histopathology of encephalitis in a Pug. J Vet Med Sci 1998;60:1353-1355.
7. Bradley GA. Myocardial necrosis in a Pug dog with necrotizing meningoencephalitis. VetPathol 1991;28:91-93.
8. Stalis IH, Chadwick B, Dayrell-Hart B, et al. Necrotizing meningoencephalitis of Maltese dogs. Vet Pathol 1995;32:230-235.
9. Kube SA, Dickinson PJ, Affolter TW, et al. Necrotizing meningoencephalitis in Chihuahua dogs. Proc 23rd ACVIM 2005;912.
10. Lotti D, Capucchio MT, Gaidolfi E, et al. Necrotizing encephalitis in a Yorkshire Terrier: Clinical, imaging, and pathologic findings. Vet Rad Ultrasound 1999;40:622-626.
11. Tipold A, Fatzer R, Jaggy A, et al. Necrotizing encephalitis in Yorkshire Terriers. J Small Anim Pract 1993;34:623-628.
12. Ducote JM, Johnson KE, Dewey CW, et al. Computed tomography of necrotizing meningoencephalitis in 3 Yorkshire Terriers. Vet Rad Ultrasound 1999;40:617-621.
13. Cantile C., Chianini F, Arispici M, et al. Necrotizing meningoencephalitis associated with cortical hippocampal hamartia in a Pekingese dog. Vet Pathol 2001;38:119-122.
14. Timmann D, Konar M, Howard J, et al. Necrotizing encephalitis in a French Bulldog. J Small Anim Pract 2007;48:339-342.
15. Schatzberg SJ, Haley NJ, Barr SC, et al. Polymerase chain reaction screening for DNA viruses in paraffin-embedded brains from dogs with necrotizing meningoencephalitis, necrotizing leukoencephalitis, and granulomatous meningoencephalitis. J Vet Intern Med 2005;19:553-559.
16. Schatzberg SJ. An update on granulomatous meningoencephalomyelitis, necrotizing meningoencephalitis, and necrotizing leukoencephalitis, In 23rd ACVIM Forum, Baltimore, MD, 2005, 351-353.
17. Uchida K, Hasegawa T, Ikeda M, et al. Detection of an autoantibody from Pug dogs with necrotizing encephalitis (Pug dog encephalitis). VetPathol 1999;36:301-307.
18. Shibuya M, Matsuki N, Fujiwara K, et al. Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis. J Vet Med Sci 2007;69:241-245.
19. Toda Y, Matsuki N, Shibuya M, et al. Glial fibrillary acidic protein (GFAP) and anti-GFAP autoantibody in canine necrotizing meningoencephalitis. Vet Rec 2007;161:261-264.
20. Matsuki N, Fujiwara K, Tamahara S, et al. Prevalence of autoantibody in cerebrospinal fluids from dogs with various CNS diseases. J Vet Med Sci 2004;66:295-297.
21. Porter BF, Ambrus A, Storts RW. Immunohistochemical evaluation of mx protein expression in canine encephalitides. Vet Pathol 2006;43:981-987.
22. Meinkoth J, Crystal M. Cerebrospinal fluid analysis. In: Cowell R. Tyler R., Meinkoth J. eds. Diagnostic Cytology and Hematology of the Dog and Cat, 2nd ed. St Louis, MO: Mosby; 1999:125-141.
23. Adamo PF, Adams WM, Steinberg H. Granulomatous menigoencephalomyelitis in dogs. Compend Contin Educ Pract Vet 2007;29:678-690.
24. Adamo PF, Rylander H, Adams WM. Ciclosporin use in multi-drug therapy for meningoencephalomyelitis of unknown etiology. J Small Anim Pract 2007;48:486-496.
25. Schwab S, Herden C, Seeliger F, et al. Non-suppurative meningoencephalitis of unknown origin in cats and dogs: An immunohistochemical study. J Comp Pathol 2007;136:96-110.
26. Zarfoss M., Schatzberg SJ, Venator K, et al. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown etiology in 10 dogs. J Small Anim Pract 2006;47:588-595.
27. Munana KR, Luttgen PJ. Prognostic factors for dogs with granulomatous meningoencephalomyelitis: 42 cases (1982-1996). J Am Vet Med Assoc 1998;212:1902-1906.
28. Coates JR, Barone G, Dewey CW, et al. Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004). J Vet Intern Med 2007;21:100 -106.
29. Sorjonen DC. Clinical and histopathological features of granulomatous meningoencephalomyelitis in dogs. J Am Anim Hosp Assoc 1990;26:141-147.
30. Bailey CS, Higgins RJ. Characteristics of cerebrospinal fluid associated with canine granulomatous meningoencephalomyelitis: A retrospective study. J Am Vet Med Assoc 1986;188:418-421.
31. Herrera BM, Cader MZ, Dyment DA, et al. Multiple sclerosis susceptibility and the X chromosome. Mult Scler 2007;13:856-864.
32. Huffman GE, Le WW, Murphy AZ, et al. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp Neurol 2001;171:272-284.
33. van den Broek HH, Damoiseaux JG, De Baets MH, et al. The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: A review. Mult Scler 2005;11:349-359.
34. Kipar A, Baumgartner W, Vogl C, et al. Immunohistochemical characterization of inflammatory cells in brains of dogs with granulomatous meningoencephalitis. Vet Pathol 1998;35:43-52.
35. Droge W, Holm E. Role of cysteine and glutathione in HIV and other diseases associated with muscle wasting and immunological dysfunction. FASEB J 1997;11:1077-1089.
36. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int J Cardiol 2002;85:89-99.
37. De Lahunta A. Diencephalon. In: Veterinary Neuroanatomy and Clinical Neurology, 2nd ed. Philadelphia, PA: WB Saunders; 1983:344-355.
38. Blanton JD, Hanlon CA, Rupprecht CE. Rabies surveillance in the United States during 2006. J Am Vet Med Assoc 2007:231:540-556.
39. Andersen O, Lygner PE, Bergstrom T, et al. Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study. J Neurol 1993;240:417-422.
40. Ogawa G, Mochizuki H, Kanzaki M, et al. Seasonal variation of multiple sclerosis exacerbations in Japan. Neurol Sci 2004:24:417-419.
41. Rosen LN, Livingstone IR, Rosenthal NE. Multiple sclerosis and latitude: A new perspective on an old association. Med Hypotheses 1991;36:376-378.
42. Schattner A. Consequence or coincidence? The occurence, pathogenesis, and significance of autoimmune manifestations after viral vaccines. Vaccine 2005;23:3876-3886.
43. Zorzon M, Zivadinov R, Nasuelli D, et al. Risk factors of multiple sclerosis: A case-control study. Neurol Sci 2003;24:242-247.
44. Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: Current understanding and controversies. Semin Neurol 2008;28:84-94.
45. Tipold A. Diagnosis of inflammatory and infectious diseases of the central nervous system in dogs: A retrospective study. J Vet Intern Med 1995;9:304-314.
46. Ravizza T, Rizzi M, Perego C, et al. Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia 2005;46(Suppl 5):113-117.
47. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995;12:326-342.
48. Henshall DC. Apoptosis signalling pathways in seizure-induced neuronal death and epilepsy. Biochem Soc Trans 2007;35:421-423.
49. Chang Y., Mellor DJ, Anderson TJ. Idiopathic epilepsy in dogs: Owners' perspectives on management with phenobarbitone and/or potassium bromide. J Small Anim Pract 2006;47: 574-581.
50. Behr S, Cauzinille L. Aseptic suppurative meningitis in juvenile Boxer dogs: Retrospective study of 12 cases. J Am An Hosp Assoc 2006;42:277-282.
51. Cizinauskas S, Jaggy A, Tipold A. Long-term treatment of dogs with steroid-responsive meningitis-arteritis: Clinical, laboratory and therapeutic results. J Small Anim Pract 2000;41:295-301.